These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22086643)

  • 1. [Estimation of chronic co-morbidity on health costs in elderly patients with neurological disorders].
    Sicras-Mainar A; Navarro-Artieda R; Ruíz-Torrejón A; Prados-Torres A;
    Rev Peru Med Exp Salud Publica; 2011; 28(3):564-5. PubMed ID: 22086643
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-benefit analysis: patient care at neurological intensive care unit.
    Kopacević L; Strapac M; Mihelcić VB
    Acta Clin Croat; 2013 Sep; 52(3):301-8. PubMed ID: 24558761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CBANCH report--the burden of neurological diseases, disorders, and injuries in Canada.
    Tator C; Bray G; Morin D
    Can J Neurol Sci; 2007 Aug; 34(3):268-9. PubMed ID: 17803022
    [No Abstract]   [Full Text] [Related]  

  • 4. Morbidity and costs associated with neurological disorders.
    Sicras-Mainar A; Navarro-Artieda R; Ruíz-Torrejón A; Prados-Torres A;
    Neurologia; 2013 Mar; 28(2):126-9. PubMed ID: 22074914
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cost of neurological disease].
    Irimia Sieira P
    Neurologia; 2008; 23(1):1-3. PubMed ID: 18365772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing wisely: highest cost tests in outpatient neurology.
    Grant PA; Walker FO; Kincaid JC
    Ann Neurol; 2014 Mar; 75(3):454. PubMed ID: 24122952
    [No Abstract]   [Full Text] [Related]  

  • 7. "We don't do neuro" or why the cost accounting of healthcare is wrong.
    Ausman JI
    Surg Neurol; 2004 Jul; 62(1):86-7. PubMed ID: 15226086
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply: To PMID 23595536.
    Burke JF; Skolarus LE; Callaghan BC; Kerber KA
    Ann Neurol; 2014 Mar; 75(3):454-5. PubMed ID: 24610607
    [No Abstract]   [Full Text] [Related]  

  • 9. [Patterns of health resources use and costs in patients with neurological disorders in primary care].
    Sicras-Mainar A; Velasco-Velasco S
    Rev Neurol; 2007 Dec 1-15; 45(11):641-6. PubMed ID: 18050094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic Diseases and Sleep.
    Barone DA; Chokroverty S
    Sleep Med Clin; 2017 Mar; 12(1):73-85. PubMed ID: 28159099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological disorders in the Global Burden of Disease 2010 study.
    Stovner LJ; Hoff JM; Svalheim S; Gilhus NE
    Acta Neurol Scand Suppl; 2014; (198):1-6. PubMed ID: 24588499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological complications of varicella in childhood: case series and a systematic review of the literature.
    Bozzola E; Tozzi AE; Bozzola M; Krzysztofiak A; Valentini D; Grandin A; Villani A
    Vaccine; 2012 Aug; 30(39):5785-90. PubMed ID: 22683522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Patient Protection and Affordable Care Act and Chronic Neurological Illnesses: Benefits and Challenges.
    Esper GJ; Hartung D; Avitzur O
    JAMA Neurol; 2015 Jul; 72(7):739-40. PubMed ID: 25938302
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurologist ambulatory care, health care utilization, and costs in a large commercial dataset.
    Ney JP; Johnson B; Knabel T; Craft K; Kaufman J
    Neurology; 2016 Jan; 86(4):367-74. PubMed ID: 26701378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of chronic neurological disease.
    Wynford-Thomas R; Robertson NP
    J Neurol; 2017 Nov; 264(11):2345-2347. PubMed ID: 29038885
    [No Abstract]   [Full Text] [Related]  

  • 16. [Incidence and cost estimation of diseases of the nervous system and the psyche. An evaluation of non-profit hospitals].
    Lampl C; Klingler D; Deisenhammer E; Neuner L; Pesec B; Hagenbichler E
    Nervenarzt; 2001 Dec; 72(12):939-45. PubMed ID: 11789439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investing in prevention: opportunities to prevent disease and reduce health care costs by identifying environmental and occupational causes of noncancer disease.
    Silbergeld E; Tonat K
    Toxicol Ind Health; 1994; 10(6):675-827. PubMed ID: 7762006
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence from cost-effectiveness research.
    Noyes K; Holloway RG
    NeuroRx; 2004 Jul; 1(3):348-55. PubMed ID: 15717037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of urinary symptoms in patients with chronic neurological disease.
    Thomas TM; Gibson M; George M; Parikshak N; Meade TW
    Community Med; 1988 May; 10(2):124-9. PubMed ID: 3243064
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost implications of outpatient teleneurology.
    Chua R; Craig J; Wootton R; Patterson V
    J Telemed Telecare; 2001; 7 Suppl 1():62-4. PubMed ID: 11576496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.